Ocular Therapeutix (OCUL) Other Gross PP&E Adjustments (2013 - 2026)
Ocular Therapeutix's quarterly Other Gross PP&E Adjustments came in at -$10.1 million in Q1 2026, down 7.67% year-on-year from -$11.0 million in Q1 2025, and down 125.15% quarter-over-quarter from $40.3 million in Q4 2025.
Ocular Therapeutix has reported Other Gross PP&E Adjustments for 14 years, with the latest figure at -$10.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 7.67% year-over-year to -$10.1 million; the trailing twelve-month figure through Mar 2026 stood at -$10.1 million (down 7.67% YoY), and the FY2025 full-year result was $40.3 million, up 135.88% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$10.1 million, down from $40.3 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $40.3 million in Q4 2025, with the low at -$10.1 million in Q1 2026.
- Average Other Gross PP&E Adjustments over 5 years is -$1.2 million, with a median of -$7.9 million recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments slumped 60.4% in 2023 and jumped 135.88% in 2025.
- Tracing OCUL's Other Gross PP&E Adjustments over 5 years: stood at $10.3 million in 2022, then soared by 46.32% to $15.1 million in 2023, then gained by 13.37% to $17.1 million in 2024, then jumped by 135.88% to $40.3 million in 2025, then sank by 125.15% to -$10.1 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$10.1 million (Q1 2026), $40.3 million (Q4 2025), and -$8.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -10.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.15 Mn |
| Mar 31, 2026 | -10.15 Mn |
| Dec 31, 2025 | 40.34 Mn |
| Dec 31, 2025 | 40.34 Mn |
| Sep 30, 2025 | -8.73 Mn |
| Sep 30, 2025 | -8.73 Mn |
| Jun 30, 2025 | -8.80 Mn |
| Jun 30, 2025 | -8.80 Mn |
| Mar 31, 2025 | -9.42 Mn |
| Mar 31, 2025 | -9.42 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | -8.83 Mn |
| Sep 30, 2024 | -8.83 Mn |
| Jun 30, 2024 | -7.75 Mn |
| Jun 30, 2024 | -7.75 Mn |
| Mar 31, 2024 | -7.95 Mn |
| Mar 31, 2024 | -7.95 Mn |
| Dec 31, 2023 | 15.08 Mn |
| Dec 31, 2023 | 15.08 Mn |
| Sep 30, 2023 | -8.22 Mn |
| Sep 30, 2023 | -8.22 Mn |
| Jun 30, 2023 | -8.64 Mn |
| Jun 30, 2023 | -8.64 Mn |
| Mar 31, 2023 | -8.66 Mn |
| Mar 31, 2023 | -8.66 Mn |
| Dec 31, 2022 | 10.31 Mn |
| Dec 31, 2022 | 10.31 Mn |
| Sep 30, 2022 | -5.31 Mn |
| Sep 30, 2022 | -5.31 Mn |
| Jun 30, 2022 | -5.39 Mn |
| Jun 30, 2022 | -5.39 Mn |
| Mar 31, 2022 | -6.14 Mn |
| Mar 31, 2022 | -6.14 Mn |
| Dec 31, 2021 | 16.07 Mn |
| Dec 31, 2021 | 16.07 Mn |
| Sep 30, 2021 | -6.52 Mn |
| Sep 30, 2021 | -6.52 Mn |
| Jun 30, 2021 | -6.46 Mn |
| Jun 30, 2021 | -6.46 Mn |
| Mar 31, 2021 | -6.90 Mn |
| Mar 31, 2021 | -6.90 Mn |
| Dec 31, 2020 | 14.17 Mn |
| Dec 31, 2020 | 14.17 Mn |
| Sep 30, 2020 | -6.76 Mn |
| Sep 30, 2020 | -6.76 Mn |
| Jun 30, 2020 | -6.27 Mn |
| Jun 30, 2020 | -6.27 Mn |
| Mar 31, 2020 | -6.47 Mn |
| Mar 31, 2020 | -6.47 Mn |
| Dec 31, 2019 | 12.50 Mn |
| Dec 31, 2019 | 12.50 Mn |
| Sep 30, 2019 | -6.84 Mn |
| Sep 30, 2019 | -6.84 Mn |
| Jun 30, 2019 | -7.01 Mn |
| Jun 30, 2019 | -7.01 Mn |
| Mar 31, 2019 | -5.16 Mn |
| Mar 31, 2019 | -5.16 Mn |
| Dec 31, 2018 | 16.47 Mn |
| Dec 31, 2018 | 16.47 Mn |
| Dec 31, 2017 | 15.29 Mn |
| Dec 31, 2017 | 15.29 Mn |
| Sep 30, 2017 | 14.37 Mn |
| Sep 30, 2017 | 14.37 Mn |
| Jun 30, 2017 | -1.47 Mn |
| Jun 30, 2017 | -1.47 Mn |
| Mar 31, 2017 | -1.60 Mn |
| Mar 31, 2017 | -1.60 Mn |
| Dec 31, 2016 | 6.11 Mn |
| Dec 31, 2016 | 6.11 Mn |
| Sep 30, 2016 | -557,000.00 |
| Sep 30, 2016 | -557,000.00 |
| Jun 30, 2016 | -577,000.00 |
| Jun 30, 2016 | -577,000.00 |
| Mar 31, 2016 | -788,000.00 |
| Mar 31, 2016 | -788,000.00 |
| Dec 31, 2015 | 5.56 Mn |
| Dec 31, 2015 | 5.56 Mn |
| Sep 30, 2015 | -544,000.00 |
| Sep 30, 2015 | -544,000.00 |
| Jun 30, 2015 | -321,000.00 |
| Jun 30, 2015 | -321,000.00 |
| Mar 31, 2015 | -252,000.00 |
| Mar 31, 2015 | -252,000.00 |
| Dec 31, 2014 | 3.67 Mn |
| Dec 31, 2014 | 3.67 Mn |
| Sep 30, 2014 | -367,000.00 |
| Sep 30, 2014 | -367,000.00 |
| Jun 30, 2014 | -587,000.00 |
| Jun 30, 2014 | -587,000.00 |
| Dec 31, 2013 | 2.49 Mn |
| Dec 31, 2013 | 2.49 Mn |